Survival into adulthood of patients with atrial isomerism undergoing cardiac surgery

Jayapadman Bhaskar1, John C Galati2, Paul Brooks3

  • 1Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Australia.

Insights

Patients with atrial isomerism face poor survival, with obstructed pulmonary venous drainage and asplenia being key mortality predictors. Survival rates remain low, especially for those with right atrial isomerism, indicating a need for improved management strategies.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Medical Genetics

Background:

  • Atrial isomerism encompasses a spectrum of complex congenital anomalies.
  • Understanding factors influencing outcomes is crucial for clinical management.

Purpose of the Study:

  • To identify determinants of adverse outcomes in patients with atrial isomerism.
  • To analyze survival predictors for left and right atrial isomerism separately.

Main Methods:

  • Retrospective analysis of patients with left and right atrial isomerism.
  • Survival determinants were assessed for the entire cohort and subgroups.
  • Statistical analysis included hazard ratios and confidence intervals.

Main Results:

  • Overall 25-year survival was 62%.
  • Independent mortality predictors included obstructed total anomalous pulmonary venous drainage and asplenia.
  • Left atrial isomerism demonstrated better survival than right atrial isomerism.
  • Specific predictors varied between left (dextrocardia, pulmonary stenosis) and right (biventricular repair, obstructed TAPVD) isomerism.

Conclusions:

  • A significant number of patients with atrial isomerism do not survive to adulthood.
  • Obstructed pulmonary venous drainage is associated with very poor survival.
  • Biventricular repair does not improve survival in right atrial isomerism.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801